Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Request
Blocked Timeslot
Restricted Timeslot
Search Exhibitors/Products
|
AbbVie |
MR Hall A1402 |
|
|
|
|
|  |  |  |
|
AbbVie |
MR Hall A1502 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1602 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1403 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1503 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1603 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1404 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1504 |
|
|
|
|
| | | |
|
AbbVie |
MR Hall A1604 |
|
|
|
|
| | | |
|
AbbVie |
917 |
|
|
|
|
| | | |
|
Actinium Pharmaceuticals |
734 |
|
|
|
|
| | | |
|
Adaptive Biotechnologies Corporation |
1701 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1112 |
|
|
|
|
| | | |
|
ADC Therapeutics |
MR Hall A1212 |
|
|
|
|
| | | |
|
ADC Therapeutics |
736 |
|
|
|
|
| | | |
|
Agios Pharmaceuticals |
1661 |
|
|
|
|
| | | |
|
Agios Pharmaceuticals |
MR Hall A1016 |
|
|
|
|
| | | |
|
Allucent |
1384 |
|
|
|
|
| | | |
|
American Association for Cancer Research |
2103 |
|
|
|
|
| | | |
|
American Porphyria Foundation |
1905 |
|
|
|
|
| | | |
|
American Society of Hematology |
1101 |
|
|
|
|
| | | |
|
American Society of Pediatric Hematology Oncology (ASPHO) |
2000 |
|
|
|
|
| | | |
|
Amgen |
MR Hall A1813 |
|
|
|
|
| | | |
|
Amgen |
451 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
MR Hall A1214 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
1229 |
|
|
|
|
| | | |
|
Apellis Pharmaceuticals |
1328 |
|
|
|
|
| | | |
|
AplusA |
665 |
|
|
|
|
| | | |
|
Arcellx |
1981 |
|
|
|
|
| | | |
|
ARUP Laboratories |
1180 |
|
|
|
|
| | | |
|
Ascentage Pharma |
2001 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1201 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1301 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1401 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1501 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1601 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1701 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1801 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1901 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2001 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2101 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1702 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1802 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A1902 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2002 |
|
|
|
|
| | | |
|
AstraZeneca |
MR Hall A2102 |
|
|
|
|
| | | |
|
AstraZeneca |
1343 |
|
|
|
|
| | | |
|
Autolus |
1615 |
|
|
|
|
| | | |
|
Azurity Pharmaceuticals, Inc |
583 |
|
|
|
|
| | | |
|
Bayer |
2135 |
|
|
|
|
| | | |
|
Beckman Coulter Life Sciences |
100 |
|
|
|
|
| | | |
|
BeiGene |
409 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A1909 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A2009 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A1910 |
|
|
|
|
| | | |
|
BeiGene USA, Inc. |
MR Hall A2010 |
|
|
|
|
| | | |
|
Best Buy Health |
116 |
|
|
|
|
| | | |
|
Blue Spark Technologies, Inc. |
120 |
|
|
|
|
| | | |
|
bluebird bio |
MR Hall A1514 |
|
|
|
|
| | | |
|
bluebird bio |
1261 |
|
|
|
|
| | | |
|
BostonGene |
1581 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
721 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1307 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1407 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1506 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1607 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1707 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1308 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1408 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1507 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1608 |
|
|
|
|
| | | |
|
Bristol Myers Squibb |
MR Hall A1708 |
|
|
|
|
| | | |
|
Cardinal Health |
577 |
|
|
|
|
| | | |
|
Caribou Biosciences, Inc. |
1173 |
|
|
|
|
| | | |
|
Caris Life Sciences |
281 |
|
|
|
|
| | | |
|
Catalyst Oncology |
167 |
|
|
|
|
| | | |
|
Children's Hospital of Philadelphia |
483 |
|
|
|
|
| | | |
|
CIBMTR (Center for International Blood & Marrow Transplant Research) |
782 |
|
|
|
|
| | | |
|
Cincinnati Childrens Hospital Medical Center |
2006 |
|
|
|
|
| | | |
|
Citius Oncology |
265 |
|
|
|
|
| | | |
|
City of Hope Comprehensive Cancer Center |
1573 |
|
|
|
|
| | | |
|
Cleveland Clinic Taussig Cancer Institute |
770 |
|
|
|
|
| | | |
|
Clinical Education Alliance |
142 |
|
|
|
|
| | | |
|
Cogent Biosciences |
728 |
|
|
|
|
| | | |
|
CRISPR Therapeutics |
1473 |
|
|
|
|
| | | |
|
CSL Behring |
1221 |
|
|
|
|
| | | |
|
Curis, Inc. |
1965 |
|
|
|
|
| | | |
|
DAVA Oncology |
2155 |
|
|
|
|
| | | |
|
DAVA Oncology |
2157 |
|
|
|
|
| | | |
|
Enable Injections |
1081 |
|
|
|
|
| | | |
|
Eurofins Viracor |
161 |
|
|
|
|
| | | |
|
Foresight Diagnostics |
2165 |
|
|
|
|
| | | |
|
Fortrea |
372 |
|
|
|
|
| | | |
|
Foundation for Sickle Cell Disease Research |
132 |
|
|
|
|
| | | |
|
Foundation for the Accreditation of Cellular Therapy |
1901 |
|
|
|
|
| | | |
|
Foundation Medicine |
MR Hall A1114 |
|
|
|
|
| | | |
|
Foundation Medicine |
1816 |
 |
|
|
|
| | | |
|
Fred Hutchinson Cancer Center |
1879 |
|
|
|
|
| | | |
|
Galapagos |
1681 |
|
|
|
|
| | | |
|
Gamida Cell |
317 |
|
|
|
|
| | | |
|
Genentech |
123 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1011 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1012 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1013 |
|
|
|
|
| | | |
|
Genentech |
MR Hall A1014 |
|
|
|
|
| | | |
|
Genomic Testing Cooperative |
2081 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
1301 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1309 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1409 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1508 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1609 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1310 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1410 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1509 |
|
|
|
|
| | | |
|
Gilead and Kite Oncology |
MR Hall A1610 |
|
|
|
|
| | | |
|
GSK |
1623 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1015 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1115 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1215 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1315 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1415 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1116 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1216 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1316 |
|
|
|
|
| | | |
|
GSK |
MR Hall A1416 |
|
|
|
|
| | | |
|
Harvest Integrated Research Organization Corp. |
150 |
|
|
|
|
| | | |
|
HealthTree Foundation |
2016 |
|
|
|
|
| | | |
|
Ichnos Glenmark Innovation |
103 |
|
|
|
|
| | | |
|
Imaging Endpoints II, LLC |
981 |
|
|
|
|
| | | |
|
Incyte Corporation |
425 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1807 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1907 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A2007 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1808 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A1908 |
|
|
|
|
| | | |
|
Incyte Corporation |
MR Hall A2008 |
|
|
|
|
| | | |
|
International Myeloma Foundation |
580 |
|
|
|
|
| | | |
|
International Myeloma Society |
1817 |
|
|
|
|
| | | |
|
Invivoscribe, Inc. |
217 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
MR Hall A1312 |
|
|
|
|
| | | |
|
Ipsen Biopharmaceuticals |
467 |
|
|
|
|
| | | |
|
IQVIA Biotech |
681 |
|
|
|
|
| | | |
|
IQVIA Laboratories |
683 |
|
|
|
|
| | | |
|
Jazz Pharmaceuticals |
1651 |
|
|
|
|
| | | |
|
Jazz Pharmaceuticals |
MR Hall A1110 |
|
|
|
|
| | | |
|
John Theurer Cancer Center |
2149 |
|
|
|
|
| | | |
|
Kedrion Biopharma |
664 |
|
|
|
|
| | | |
|
Kyowa Kirin, Inc. |
611 |
|
|
|
|
| | | |
|
Legend Biotech |
401 |
|
|
|
|
| | | |
|
Machaon Diagnostics, Inc. |
475 |
|
|
|
|
| | | |
|
Mallinckrodt Pharmaceuticals |
1863 |
|
|
|
|
| | | |
|
MD Anderson Cancer Center |
1711 |
|
|
|
|
| | | |
|
Mechatronics Instruments B.V. |
2079 |
|
|
|
|
| | | |
|
Med Learning Group |
1781 |
|
|
|
|
| | | |
|
Med Learning Group |
971 |
|
|
|
|
| | | |
|
MedGenome |
165 |
|
|
|
|
| | | |
|
Medpace Inc. |
2121 |
|
|
|
|
| | | |
|
Medscape Oncology & Hematology |
443 |
|
|
|
|
| | | |
|
Menarini Silicon Biosystems |
1775 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1911 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2011 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1912 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2012 |
|
|
|
|
| | | |
|
Merck |
MR Hall A1913 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2013 |
|
|
|
|
| | | |
|
Merck |
MR Hall A2112 |
|
|
|
|
| | | |
|
Merck & Co., Inc. |
201 |
|
|
|
|
| | | |
|
Miltenyi Biomedicine GmbH |
1271 |
|
|
|
|
| | | |
|
Mission Bio |
2129 |
|
|
|
|
| | | |
|
Moffitt Cancer Center |
2015 |
|
|
|
|
| | | |
|
National Comprehensive Cancer Network (NCCN) |
1801 |
|
|
|
|
| | | |
|
NeoGenomics |
1971 |
|
|
|
|
| | | |
|
NMDP |
780 |
|
|
|
|
| | | |
|
Northside Hospital |
113 |
|
|
|
|
| | | |
|
Novartis |
642 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1703 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1803 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1903 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1704 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1804 |
|
|
|
|
| | | |
|
Novartis |
MR Hall A1904 |
|
|
|
|
| | | |
|
Novo Nordisk Healthcare AG |
1161 |
|
|
|
|
| | | |
|
Ohio State’s Comprehensive Cancer Center–James Cancer Hospital & Solove Research Institute |
181 |
|
|
|
|
| | | |
|
Ohio State’s Comprehensive Cancer Center–James Cancer Hospital & Solove Research Institute |
V100 |
|
|
|
|
| | | |
|
OHSU Knight Cancer Institute |
1809 |
|
|
|
|
| | | |
|
Omeros Corporation |
769 |
|
|
|
|
| | | |
|
ONO PHARMA |
2063 |
|
|
|
|
| | | |
|
ONO PHARMA |
MR Hall A1113 |
|
|
|
|
| | | |
|
Ontada |
174 |
|
|
|
|
| | | |
|
Orca Bio |
1011 |
|
|
|
|
| | | |
|
Ossium Health, Inc. |
112 |
|
|
|
|
| | | |
|
Parexel |
260 |
|
|
|
|
| | | |
|
PharmaEssentia Corporation |
1501 |
|
|
|
|
| | | |
|
Pixelgen Technologies |
182 |
|
|
|
|
| | | |
|
Precision for Medicine |
671 |
|
|
|
|
| | | |
|
Predicine |
156 |
|
|
|
|
| | | |
|
Protagonist Therapeutics, Inc |
1111 |
|
|
|
|
| | | |
|
Prothena |
MR Hall A1111 |
|
|
|
|
| | | |
|
Prothena |
911 |
|
|
|
|
| | | |
|
PSI CRO |
1871 |
|
|
|
|
| | | |
|
Quest Diagnostics |
1083 |
|
|
|
|
| | | |
|
Ranfac Corp |
367 |
|
|
|
|
| | | |
|
Rapid Novor Inc. |
2106 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
MR Hall A1914 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
670 |
|
|
|
|
| | | |
|
Recordati Rare Diseases |
672 |
|
|
|
|
| | | |
|
Regeneron Pharmaceuticals, Inc. |
MR Hall A1411 |
|
|
|
|
| | | |
|
Regeneron Pharmaceuticals, Inc. |
MR Hall A1510 |
|
|
|
|
| | | |
|
Regeneron Pharmaceuticals, Inc. |
MR Hall A1611 |
|
|
|
|
| | | |
|
Regeneron Pharmaceuticals, Inc. |
MR Hall A1412 |
|
|
|
|
| | | |
|
Regeneron Pharmaceuticals, Inc. |
MR Hall A1612 |
|
|
|
|
| | | |
|
Regeneron Pharmaceuticals, Inc. |
901 |
|
|
|
|
| | | |
|
Roswell Park Comprehensive Cancer Center |
2179 |
|
|
|
|
| | | |
|
Rutgers Cancer Institute/RWJBarnabas Health |
2113 |
|
|
|
|
| | | |
|
Sanguina, Inc. |
481 |
|
|
|
|
| | | |
|
Sarah Cannon Research Institute |
1580 |
|
|
|
|
| | | |
|
Scopio Labs |
584 |
|
|
|
|
| | | |
|
Sebia |
2009 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1313 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
MR Hall A1413 |
|
|
|
|
| | | |
|
Servier Pharmaceuticals |
461 |
|
|
|
|
| | | |
|
SOBI, Inc |
1643 |
|
|
|
|
| | | |
|
SOBI, Inc |
MR Hall A2015 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1815 |
|
|
|
|
| | | |
|
SOBI, Inc. |
MR Hall A1915 |
|
|
|
|
| | | |
|
Society for Immunotherapy of Cancer (SITC) |
2014 |
|
|
|
|
| | | |
|
Spark Therapeutics, Inc. |
136 |
|
|
|
|
| | | |
|
St. Jude Children's Research Hospital |
1915 |
|
|
|
|
| | | |
|
Star Therapeutics |
104 |
|
|
|
|
| | | |
|
STEMCELL Technologies |
2125 |
|
|
|
|
| | | |
|
Stemline Therapeutics, Inc. |
MR Hall A1007 |
|
|
|
|
| | | |
|
Stemline Therapeutics, Inc. |
1562 |
|
|
|
|
| | | |
|
Syneos Health |
619 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1709 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1809 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1710 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1810 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1711 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1811 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1712 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1812 |
|
|
|
|
| | | |
|
Takeda |
MR Hall A1713 |
|
|
|
|
| | | |
|
Takeda |
1242 |
|
|
|
|
| | | |
|
Team Telomere |
1811 |
|
|
|
|
| | | |
|
Telo Genomics |
785 |
|
|
|
|
| | | |
|
Tempus |
2108 |
|
|
|
|
| | | |
|
The MDS Foundation, Inc. |
1815 |
|
|
|
|
| | | |
|
ThermoFisher |
2071 |
|
|
|
|
| | | |
|
United Porphyrias Association |
1911 |
|
|
|
|
| | | |
|
Vaniam Group |
775 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1210 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1211 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
MR Hall A1311 |
|
|
|
|
| | | |
|
Vertex Pharmaceuticals Inc. |
1831 |
|
|
|
|
| | | |
|
Worldwide Clinical Trials |
160 |
|
|
|
|
| | | |
|
Wuhan Kindstar Medical Laboratory Limited Company |
1181 |
|
|
|
|
| | | |
|
X4 Pharmaceuticals |
730 |
|
|
|
|
| | | |